Skip to content
Home/Companies/Healthcare/Righton Gene (688217.SH)
RG

Righton Gene (688217.SH)

Healthcare·China·Active·8yr hold

Righton Gene (688217.SH) is a healthcare company, headquartered in China.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns Righton Gene (688217.SH)?

Righton Gene (688217.SH) is currently owned by Cathay Capital through Cathay Capital Small Cap III (2016 vintage), since 2018.

Hand-verified · updated 2026-04-21

Cathay Capital
Investor
Cathay Capital
Cathay Capital Small Cap III · 2016 · Growth

Key facts

HQChina
SectorHealthcare

More from Cathay Capital Small Cap III

Other portfolio companies in the same fund.

Aukey
Active
ConsumerChina· 2020
Biose Industrie
Exited 2024
HealthcareFrance· 2020
to
Brosmed
Active
HealthcareChina· 2020
Deerma
Active
ConsumerChina· 2020
EasyVista
Active
SoftwareFrance· 2020
Fapon
Active
HealthcareChina· 2020

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abcam (exited)
Active
EMV CapitalUK
Data refreshed weekly · Sourced from public filings